tirzepatide removed from shortage list FDA reconsidering its decision to take off its drug tirzepatide march 19th FDA Announced

First-Gen GLP-1s vs Second-Gen GLP-1s There are different types of GLP-1s

Key Any updates how is it going Related posts Week 1 Wegovy Pill Check-In Week one on the Wegovy pill and heres the real update not the highlight-reel version

Serve with 1 slice of whole-grain toast and a side of cup of cantaloupe cubes

Incretin-based therapies: viewpoints on the way to consensus

This approach is not cost-effective because CGMs account for only 1.1% of the total cost of diabetes, while the costs of treating complications and lost productivity -- both expenses that would be reduced with widespread CGM use -- account for 73.1% of total diabetes costs